These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10521994)

  • 1. Practicality of 5-aminosalicylic suppositories for long-term treatment of inactive distal ulcerative colitis.
    Casellas F; Vaquero E; Armengol JR; Malagelada JR
    Hepatogastroenterology; 1999; 46(28):2343-6. PubMed ID: 10521994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: long-term results.
    Guarino J; Chatzinoff M; Berk T; Friedman LS
    Am J Gastroenterol; 1987 Aug; 82(8):732-7. PubMed ID: 3496786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
    Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitis.
    Hanauer S; Good LI; Goodman MW; Pizinger RJ; Strum WB; Lyss C; Haber G; Williams CN; Robinson M
    Am J Gastroenterol; 2000 Jul; 95(7):1749-54. PubMed ID: 10925979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis.
    Marshall JK; Irvine EJ
    Am J Gastroenterol; 2000 Jul; 95(7):1628-36. PubMed ID: 10925961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent versus continuous 5-aminosalicylic acid treatment for maintaining remission in ulcerative colitis.
    Bardazzi G; d'Albasio G; Bonanomi AG; Trallori G; Messori A; Amorosi A; Bartoletti L; Morettini A; Pacini F
    Ital J Gastroenterol; 1994 Sep; 26(7):334-7. PubMed ID: 7812025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study.
    d'Albasio G; Pacini F; Camarri E; Messori A; Trallori G; Bonanomi AG; Bardazzi G; Milla M; Ferrero S; Biagini M; Quaranta S; Amorosi A
    Am J Gastroenterol; 1997 Jul; 92(7):1143-7. PubMed ID: 9219787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beclomethasone dipropionate (3 mg) enemas combined with oral 5-ASA (2.4 g) in the treatment of ulcerative colitis not responsive to oral 5-ASA alone.
    D'Arienzo A; Manguso F; Castiglione GN; Vicinanza G; Scaglione G; Bennato R; Sanges M; Mazzacca G
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):254-7. PubMed ID: 9759590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Aminosalicylic acid suppositories in the maintenance of remission in idiopathic proctitis or proctosigmoiditis: a double-blind placebo-controlled clinical trial.
    D'Arienzo A; Panarese A; D'Armiento FP; Lancia C; Quattrone P; Giannattasio F; Boscaino A; Mazzacca G
    Am J Gastroenterol; 1990 Sep; 85(9):1079-82. PubMed ID: 2202199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX with Asacol.
    Prantera C; Kohn A; Campieri M; Caprilli R; Cottone M; Pallone F; Savarino V; Sturniolo GC; Vecchi M; Ardia A; Bellinvia S
    Aliment Pharmacol Ther; 2009 Nov; 30(9):908-18. PubMed ID: 19678813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
    Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis.
    Eliakim R; Tulassay Z; Kupcinskas L; Adamonis K; Pokrotnieks J; Bar-Meir S; Lavy A; Mueller R; Greinwald R; Chermesh I; Gross V;
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1237-49. PubMed ID: 17944738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulcerative proctitis: a review of pharmacotherapy and management.
    Lakatos PL; Lakatos L
    Expert Opin Pharmacother; 2008 Apr; 9(5):741-9. PubMed ID: 18345952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial.
    Friedman LS; Richter JM; Kirkham SE; DeMonaco HJ; May RJ
    Am J Gastroenterol; 1986 Jun; 81(6):412-8. PubMed ID: 3518408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug therapy for ulcerative colitis: salazosulfapyridine and 5-ASA].
    Jo Y; Matsumoto T; Iida M
    Nihon Rinsho; 2005 May; 63(5):820-4. PubMed ID: 15881176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative, open, randomized trial of the efficacy and tolerance of slow-release 5-ASA suppositories once daily versus conventional 5-ASA suppositories twice daily in the treatment of active cryptogenic proctitis: French Pentasa Study Group.
    Marteau P; Florent C
    Am J Gastroenterol; 2000 Jan; 95(1):166-70. PubMed ID: 10638577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
    Hanauer SB; Sandborn WJ; Kornbluth A; Katz S; Safdi M; Woogen S; Regalli G; Yeh C; Smith-Hall N; Ajayi F
    Am J Gastroenterol; 2005 Nov; 100(11):2478-85. PubMed ID: 16279903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic uptake of 5-aminosalicylic acid from olsalazine and eudragit L coated mesalazine in patients with ulcerative colitis in remission.
    Ewe K; Becker K; Ueberschaer B
    Z Gastroenterol; 1996 Apr; 34(4):225-9. PubMed ID: 8686349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis.
    Lichtenstein GR; Kamm MA; Boddu P; Gubergrits N; Lyne A; Butler T; Lees K; Joseph RE; Sandborn WJ
    Clin Gastroenterol Hepatol; 2007 Jan; 5(1):95-102. PubMed ID: 17234558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term intermittent treatment with low-dose 5-aminosalicylic enemas is efficacious for remission maintenance in ulcerative colitis.
    Piodi LP; Ulivieri FM; Cermesoni L; Cesana BM
    Scand J Gastroenterol; 2004 Feb; 39(2):154-7. PubMed ID: 15000277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.